Appearing on Fox News, the CEO of Moderna, Stéphane Bancel, struggled to explain why SARS-CoV-2 contains a gene sequence that was patented by Moderna three years before the pandemic.
Scientists Find Genetic Insert in SARS-CoV-2 That Matches Sequence Patented by Moderna 3 Years Before Pandemic
Fresh suspicion that SARS-CoV-2 came from a lab emerged this week after scientists announced they had found a genetic insert—CTCCTCGGCGGGCACGTAG—in the spike protein of the virus that only exists in Moderna patent 9,587,003 from three years before the pandemic.
The patented sequence is part of a gene called MSH3 that is known to affect how damaged cells repair themselves in the body.
In their study, published (https://www.frontiersin.org/articles/10.3389/fviro.2022.834808/full) Monday (Feb. 21) in Frontiers in Virology, researchers compared SARS-CoV-2’s makeup—which is made up of 30,000 letters of genetic code—to millions of sequenced proteins in a massive online database.
That’s when they discovered a genetic sequence owned by Moderna in SARS-CoV-2’s unique furin cleavage site, the part that makes it so good at infecting humans and separates it from other coronaviruses.